Great Lakes Advisors, LLC Sangamo Therapeutics, Inc Transaction History

Great Lakes Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.28 - $6.21 $1.72 Million - $3.25 Million	-523,194 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$5.23 - $7.82 $677,248 - $1.01 Million	-129,493 Reduced 19.84%	523,194 $3.04 Million
Q4 2021 Feb 09, 2022	SELL	$7.29 - $10.97 $105,945 - $159,427	-14,533 Reduced 2.18%	652,687 $4.9 Million
Q3 2021 Nov 09, 2021	SELL	$9.01 - $12.01 $223,051 - $297,319	-24,756 Reduced 3.58%	667,220 $6.01 Million
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $27,397 - $34,052	-2,694 Reduced 0.39%	691,976 $8.28 Million
Q1 2021 May 03, 2021	BUY	$10.88 - $17.05 $417,335 - $654,003	38,358 Added 5.84%	694,670 $8.7 Million
Q4 2020 Feb 09, 2021	SELL	$9.23 - $18.18 $3.21 Million - $6.32 Million	-347,413 Reduced 34.61%	656,312 $10.2 Million
Q3 2020 Nov 04, 2020	BUY	$9.38 - $12.48 $1.52 Million - $2.02 Million	161,549 Added 19.18%	1,003,725 $9.49 Million
Q2 2020 Aug 07, 2020	BUY	$6.21 - $11.83 $5.23 Million - $9.96 Million	842,176 New	842,176 $7.55 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $305M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.